6 March 2025
Weil Advises PSG Equity in Relation to Eurazeo’s Investment in Mapal and the Sale of a Majority Stake to Eurazeo
Advising firms
Deal team
12 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Lewis Blakey Lead | Weil | Partner | Private Equity | Not stated |
| Priya Shah | Weil | Associate | Private Equity | Not stated |
| Xavier Khan | Weil | Associate | Private Equity | Not stated |
| Oliver Walker | Weil | Partner | Tax | Not stated |
| Ellie Marques | Weil | Counsel | Not stated | Not stated |
| Anna Ritchie | Weil | Associate | Not stated | Not stated |
| Kevin Donegan | Weil | Counsel | Incentives | Not stated |
| Neil Rigby | Weil | Partner | Antitrust | Not stated |
| Nicholas Barnabo | Weil | Counsel | Antitrust | Not stated |
| Lucy Peckham | Weil | Associate | Antitrust | Not stated |
| Patrick Brendon | Weil | Partner | Finance | Not stated |
| Natalie Hellio | Weil | Associate | Finance | Not stated |
9 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- PSG EquityBuy-side
- Counterparties
- Eurazeo (Sell-side)
Mapal (Target)